Skip to search formSkip to main contentSkip to account menu

avibactam / Ceftazidime

Known as: AVIBACTAM/CEFTAZIDIME, ceftazidime-avibactam, avibactam - ceftazidime 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (1)

Avycaz

Broader (2)

Azabicyclo Compoundsbeta-Lactamase Inhibitors
Ceftazidimeavibactam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales.
BACKGROUND In vitro data support the use of combination of aztreonam (ATM) with ceftazidime-avibactam (CAZ-AVI), but clinical… 
Highly Cited
2019
Highly Cited
2019
Exploring Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam as Potential Treatments for Metallo- and Serine-β-Lactamase-Producing Enterobacteriaceae
Metallo-β-lactamase (MBL)-producing Enterobacteriaceae, particularly those that coharbor serine β-lactamases, are a serious… 
Highly Cited
2019
Highly Cited
2019
Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria
Metallo-β-lactamase (MBL)-producing Gram-negative bacteria are often extremely resistant, leading to a real therapeutic dead end… 
Review
2018
Review
2018
Optimizing therapy in CRE infections.
PURPOSE OF REVIEW In the absence of randomized clinical trial data, questions remain regarding the optimal treatment of… 
Highly Cited
2018
Highly Cited
2018
The Inoculum Effect in the Era of Multidrug Resistance: Minor Differences in Inoculum Have Dramatic Effect on MIC Determination
ABSTRACT The observed MIC may depend on the number of bacteria initially inoculated into the assay. This phenomenon is termed the… 
Highly Cited
2016
Highly Cited
2016
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms
ABSTRACT Ceftazidime-avibactam (CAZ-AVI) is a recently approved β-lactam–β-lactamase inhibitor combination with the potential to… 
Highly Cited
2016
Highly Cited
2016
Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
ABSTRACT We compared ceftazidime-avibactam, ceftolozane-tazobactam, ceftazidime, cefepime, and piperacillin-tazobactam MICs for… 
Review
2016
Review
2016
Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
Review
2015
Review
2015
A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens.
Review
2015
Review
2015
The β‐Lactams Strike Back: Ceftazidime‐Avibactam
Gram‐negative resistance has reached a crucial point, with emergence of pathogens resistant to most or all available antibiotics… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)